Technology | April 24, 2015

Submission includes clinical validation and internal software testing for CAD plus digital radiography versus DR alone

VuComp, M-Vu CAD, digital breast tomosynthesis, DBT

April 24, 2015 — VuComp Inc. announced that it has submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for computer-aided detection (CAD) for digital breast tomosynthesis (DBT).

The CAD system is designed to use VuComp proprietary computer vision algorithms (M-Vu Algorithm Engine) to identify areas of mammograms consistent with breast cancer.

The submission includes both clinical validation and internal software testing that compares CAD performance of DBT and digital radiography (DR) images to DR images alone.  

Use of CAD with breast tomosynthesis is expected to re-ignite CAD for the mammography market. Installations of tomosynthesis systems are expected to increase four-fold in the United States by 2016. With tomosynthesis adoption continuing to grow, demand for a tool to help the radiologist assess the vast amount of data is expected. Tomosynthesis provides 50 to 100 times as much data as 2-D mammography studies.

Debra Somers Copit, M.D., FACR, director, breast imaging, Einstein Healthcare Network and associate professor of radiology, Jefferson Medical College commented, “DBT clearly decreases the recall rates for screening mammography and increases invasive cancer detection. Yet, there is a critical role for CAD not only for the radiologist new to tomosynthesis, but also those who have had more experience, given the vastly increased amount of information presented to the reader.”

VuComp anticipates the launch of their CAD for tomosynthesis solution no later than the fourth quarter of 2015.

VuCOMP’s M-Vu CAD system meets the FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.

For more information: www.vucomp.com


Related Content

News | Women's Health

October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
arrow
News | Mammography

September 22, 2023 — Hologic Inc. and Bayer announced an international partnership to deliver contrast-enhanced ...

Time September 22, 2023
arrow
News | Digital Pathology

September 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time September 22, 2023
arrow
Feature | Breast Imaging | By Susan Harvey, MD, FSBI

In countries with organized screening programs, regular breast cancer screening has been a crucial tool in the clinician ...

Time September 22, 2023
arrow
News | Mammography Reporting Software

September 13, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has ...

Time September 13, 2023
arrow
News | Mammography

September 13, 2023 — Lene Andersen, MSW, has been living with rheumatoid arthritis and disability since childhood. Her ...

Time September 13, 2023
arrow
News | Breast Density

September 12, 2023 — DenseBreast-info.org (DBI), a leading website on the topic of dense breasts, has announced that the ...

Time September 12, 2023
arrow
Subscribe Now